2nd Quarter - Amendment

CURA STRATEGIES for PKD FOUNDATION

Firm
Client
Income
$10,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 22, 2025 $10,000 Replaced
2nd Quarter - Amendment Jul 31, 2026 $10,000 Replaced
2nd Quarter - Amendment (this page) Jul 31, 2026 $10,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Federal funding for PKD research.

LobbyistCovered position, as disclosed
SCOTT C LEEZER Aide to Senator Dick Durbin (D-IL)
PATRICK MEADE New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Policies to encourage organ donation.

LobbyistCovered position, as disclosed
SCOTT C LEEZER Aide to Senator Dick Durbin (D-IL)
PATRICK MEADE New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Defense DEF

Inclusion of PKD as a covered topic area under the Peer Reviewed Medical Research Program.

LobbyistCovered position, as disclosed
SCOTT C LEEZER Aide to Senator Dick Durbin (D-IL)
PATRICK MEADE New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.